EKF Diagnostics (LON:EKF) Shares Cross Below 200 Day Moving Average – Here’s What Happened
by Tristan Rich · The Markets DailyEKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 25.64 and traded as low as GBX 25.21. EKF Diagnostics shares last traded at GBX 25.82, with a volume of 167,983 shares.
Wall Street Analysts Forecast Growth
Separately, Stifel Nicolaus reiterated a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 35.
Read Our Latest Stock Report on EKF Diagnostics
EKF Diagnostics Stock Performance
The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77. The business has a 50-day moving average of GBX 26.05 and a 200-day moving average of GBX 25.64. The company has a market capitalization of £111.10 million, a P/E ratio of 54.94 and a beta of 0.51.
EKF Diagnostics Company Profile
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- Financials Hit Record Highs as the AI Trade Unravels—Can They Keep Leading?
- Netflix’s Big Sell-Off May Be Sending the Wrong Signal
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus